Multicenter observational study of chemotherapy-induced peripheral neuropathy preventio
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000043729
- Lead Sponsor
- Kyoto Breast Cancer Research Network (KBCRN)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 480
Not provided
1)Patients who have CTCAE more than grade1 neuropathy and/or skin disorders 2)Patients taking pregabalin, etc. to control neuropathic pain 3)active double cancer (except lesions corresponding to carcinoma in situ or intramucosal cancer that are judged to be cured by local treatment are not included in the double cancer). 4)active brain metastasis 5)Diabetes mellitus with peripheral neuropathy, infectious diseases (on limbs) that are judged to interfere with prevention, and other serious complications are observed. 6)History of severe drug hypersensitivity in therapeutically important drugs in this study 7)History of serious mental illness or under treatment 8)HBsAg positive and untreated 9)History of serious heart or respiratory illness 10)May be pregnant or pregnant 11)In addition, when the principal investigator or the research coordinator determines that the subject is inappropriate (specific example: signs of peripheral circulatory insufficiency such as Raynaud's phenomenon)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method